$80M Private Placement Funds Ronde-Cel Push Toward BLA Filing
LYEL sits 50% above its 52-week low of $7.195.
Summary
Lyell is raising $80M through a private placement, with proceeds earmarked to push its lead CAR-T candidate ronde-cel toward a planned BLA submission. The raise is large relative to the company's roughly $264M market cap, so dilution is the immediate question — the terms (price per share, discount to the $10.77 last trade, investor identity) are not disclosed in the headline. It follows the September 8-K where Lyell completed the LYL273 manufacturing transfer to its LyFE facility and reset the expected data readout and end-of-phase timing, so the cash is aimed at keeping the ronde-cel timeline intact. Watch for the 8-K with pricing and warrant terms, which will determine how much of the raise is straight equity versus structured paper.
At the time of this announcement, LYEL was trading at $10.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $263.9M. The 52-week trading range was $7.20 to $45.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.